Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche

Blood

Volumn 123, Issue 9, 2014, Pages 1361-1371

  Krause, Daniela S ^a,b   Lazarides, Katherine ^a   Lewis, Juliana B ^a,d   Von Andrian, Ulrich H ^c   Van Etten, Richard A ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BCR ABL PROTEIN; BETA1 INTEGRIN; CD18 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CRE RECOMBINASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUCOSYLTRANSFERASE; L SELECTIN; LEUKOCYTE FUNCTIONAL ANTIGEN 1; LIGAND; N ACETYLGLUCOSAMINYLTRANSFERASE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; RETROVIRUS VECTOR; SELECTIN; SIALIDASE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BCR ABL1 LEUKEMIA STEM CELL; BONE MARROW; CELL ADHESION; CELL HOMING; CHRONIC MYELOID LEUKEMIA; CLONAL VARIATION; CONTROLLED STUDY; ENDOTHELIUM; ENGRAFTMENT; GERMLINE MUTATION; LECTIN BINDING; LEUKEMOGENESIS; LEUKOCYTE COUNT; MOUSE; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; PRE T LYMPHOCYTE; PRIORITY JOURNAL; STEM CELL; STEM CELL NICHE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CANCER STEM CELL; CELL CULTURE; CELL MOTION; CELL STRAIN HEK293; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR INVASION;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL MOVEMENT; CELLS, CULTURED; FUSION PROTEINS, BCR-ABL; HEK293 CELLS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LIGANDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; SELECTINS; STEM CELL NICHE;

EID: 84899047394     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-11-538694     Document Type: Article

References (56)

1. O'Brien SG, Guilhot F, Larson RA, et al IRIS Investigators. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003;348(11):994-1004. (Pubitemid 36302244)
2. Graham SM, Jørgensen HG, Allan E, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002; 99(1):319-325.
3. Bhatia R, McGlave PB. Autologous hematopoietic cell transplantation for chronic myelogenous leukemia. Hematol Oncol Clin North Am. 2004; 18(3):715-732. (Pubitemid 38969141)
4. Singer JW, Arlin ZA, Najfeld V, et al. Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome. Blood. 1980;56(3): 356-360. (Pubitemid 11251012)
5. Verfaillie CM, Bhatia R, Miller W, et al. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Blood. 1996;87(11):4770-4779.
6. Carella AM, Lerma E, Corsetti MT, et al. Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. Blood. 1999; 93(5):1534-1539. (Pubitemid 29102480)
7. Pigneux A, Faberes C, Boiron JM, et al. Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience. Bone Marrow Transplant. 1999;24(3):265-270. (Pubitemid 29377865)
8. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood. 1994; 83(10):3068-3076.
9. de Fabritis P, Amadori S, Petti MC, et al. In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantation. Leukemia. 1995;9(4): 662-664.
10. Luger SM, O'Brien SG, Ratajczak J, et al. Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study. Blood. 2002;99(4): 1150-1158. (Pubitemid 34547066)
11. Barnett MJ, Eaves CJ, Phillips GL, et al. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood. 1994;84(3):724-732. (Pubitemid 24223866)
12. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106(6):1901-1910. (Pubitemid 41291700)
13. Papayannopoulou T. Bone marrow homing: the players, the playfield, and their evolving roles. Curr Opin Hematol. 2003;10(3):214-219. (Pubitemid 36528977)
14. Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA. 1995; 92(21):9647-9651.
15. van der Loo JC, Xiao X, McMillin D, Hashino K, Kato I, Williams DA. VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest. 1998;102(5):1051-1061. (Pubitemid 28419251)
16. Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD, von Andrian UH. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med. 1998;188(3):465-474. (Pubitemid 28369136)
17. Frenette PS, Subbarao S, Mazo IB, von Andrian UH, Wagner DD. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci USA. 1998;95(24): 14423-14428. (Pubitemid 28549383)
18. Potocnik AJ, Brakebusch C, Fässler R. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity. 2000;12(6):653-663.
19. Scott LM, Priestley GV, Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol. 2003; 23(24):9349-9360. (Pubitemid 37499821)
20. Peled A, Kollet O, Ponomaryov T, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood. 2000; 95(11):3289-3296. (Pubitemid 30428455)
21. Papayannopoulou T, Priestley GV, Nakamoto B, Zafiropoulos V, Scott LM. Molecular pathways in bone marrow homing: dominant role of alpha(4) beta(1) over beta(2)-integrins and selectins. Blood. 2001;98(8):2403-2411.
22. Vermeulen M, Le Pesteur F, Gagnerault M-C, Mary J-Y, Sainteny F, Lepault F. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood. 1998;92(3):894-900. (Pubitemid 28355472)
23. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999; 283(5403):845-848.
24. Bonig H, Priestley GV, Papayannopoulou T. Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. Blood. 2006;107(1):79-86. (Pubitemid 43053527)
25. Kawabata K, Ujikawa M, Egawa T, et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci USA. 1999;96(10):5663-5667. (Pubitemid 29234675)
26. Avigdor A, Goichberg P, Shivtiel S, et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood. 2004;103(8):2981-2989. (Pubitemid 38451670)
27. Oostendorp RA, Ghaffari S, Eaves CJ. Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organ-specific but CD44-independent. Bone Marrow Transplant. 2000;26(5):559-566.
28. Bhatia R, McCarthy JB, Verfaillie CM. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Blood. 1996;87(9): 3883-3891. (Pubitemid 26129618)
29. Salgia R, Quackenbush E, Lin J, et al. The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha. Blood. 1999;94(12):4233-4246.
30. Peled A, Hardan I, Trakhtenbrot L, et al. Immature leukemic CD341CXCR41 cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1. Stem Cells. 2002;20(3):259-266. (Pubitemid 34507442)
31. Kimura A, Kawaishi K, Sasaki A, Hyodo H, Oguma N. L-selectin expression in CD34 positive cells in chronic myeloid leukemia. Leuk Lymphoma. 1998;28(3-4):399-404. (Pubitemid 28105047)
32. Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG, Van Etten RA. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood. 2001;97(5): 1442-1450. (Pubitemid 32183771)
33. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med. 2006;12(10):1175-1180. (Pubitemid 44527353)
34. Xia L, Sperandio M, Yago T, et al. P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest. 2002;109(7):939-950. (Pubitemid 34275115)
35. Protin U, Schweighoffer T, Jochum W, Hilberg F. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol. 1999;163(9): 4917-4923. (Pubitemid 29501257)
36. Snapp KR, Heitzig CE, Ellies LG, Marth JD, Kansas GS. Differential requirements for the O-linked branching enzyme core 2 beta1-6-N- glucosaminyltransferase in biosynthesis of ligands for E-selectin and P-selectin. Blood. 2001; 97(12):3806-3811.
37. Koni PA, Joshi SK, Temann U-A, Olson D, Burkly L, Flavell RA. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. 2001; 193(6):741-754.
38. Mazurier F, Doedens M, Gan OI, Dick JE. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med. 2003;9(7): 959-963. (Pubitemid 36889941)
39. Dimitroff CJ, Lee JY, Fuhlbrigge RC, Sackstein R. A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci USA. 2000;97(25):13841-13846.
40. Malý P, Thall AD, Petryniak B, et al. The alpha(1,3) fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 1996;86(4):643-653. (Pubitemid 26299495)
41. Brakebusch C, Fillatreau S, Potocnik AJ, et al. Beta1 integrin is not essential for hematopoiesis but is necessary for the T cell-dependent IgM antibody response. Immunity. 2002;16(3): 465-477. (Pubitemid 34260923)
42. Katayama Y, Hidalgo A, Furie BC, Vestweber D, Furie B, Frenette PS. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood. 2003;102(6):2060-2067. (Pubitemid 37122380)
43. Lowe JB. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr Opin Cell Biol. 2003;15(5):531-538. (Pubitemid 37176961)
44. Lévesque JP, Zannettino AC, Pudney M, et al. PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity. 1999; 11(3):369-378. (Pubitemid 29463245)
45. Sperandio M, Smith ML, Forlow SB, et al. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med. 2003;197(10):1355-1363. (Pubitemid 36617782)
46. Homeister JW, Thall AD, Petryniak B, et al. The alpha(1,3) fucosyltransferases FucT-IV and FucT-VII exert collaborative control over select-independent leukocyte recruitment and lymphocyte homing. Immunity. 2001;15(1):115-126. (Pubitemid 32728325)
47. Shaner NC, Campbell RE, Steinbach PA, Giepmans BNG, Palmer AE, Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol. 2004;22(12): 1567-1572. (Pubitemid 40039460)
48. Wagers AJ, Stoolman LM, Craig R, Knibbs RN, Kansas GS. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins. J Immunol. 1998;160(10):5122-5129. (Pubitemid 28215351)
49. Frenette PS, Moyna C, Hartwell DW, Lowe JB, Hynes RO, Wagner DD. Platelet-endothelial interactions in inflamed mesenteric venules. Blood. 1998;91(4):1318-1324. (Pubitemid 28086885)
50. Venturi GM, Tu L, Kadono T, et al. Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity. 2003;19(5): 713-724. (Pubitemid 37490796)
51. Robert C, Klein C, Cheng G, et al. Gene therapy to target dendritic cells from blood to lymph nodes. Gene Ther. 2003;10(17):1479-1486. (Pubitemid 36987142)
52. von Andrian UH, Hasslen SR, Nelson RD, Erlandsen SL, Butcher EC. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell. 1995;82(6):989-999.
53. Fruehauf S, Topaly J, Schad M, et al. Imatinib restores expression of CD62L in BCR-ABLpositive cells. J Leukoc Biol. 2003;73(5):600-603. (Pubitemid 38040472)
54. Pelletier SD, Hong DS, Hu Y, Liu Y, Li S. Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice. Blood. 2004;104(7):2163-2171. (Pubitemid 39297872)
55. Wetzler M, Watson D, Stock W, et al. Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance) [published online ahead of print September 27, 2013]. Haematologica.
56. Telen MJ, Wun T, McCavit TL, et al. GMI 1070: Reduction in time to resolution of vaso-occlusive crisis and decreased opioid use in a prospective, randomized, multi-center double blind, adaptive phase 2 study in sickle cell disease. Blood. 2013; 122(21):776a.